<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20170116031972N7</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-07-10</date_registration>
      <primary_sponsor>Kerman University of Medical Sciences</primary_sponsor>
      <public_title>The effect of accupressure and cryotherapy on the pain of the injection in the arteriovenous fistula in the patients under hemodialysis</public_title>
      <acronym></acronym>
      <scientific_title>The comparative effect of acupressure and cryotherapy on the pain of the injection in the arteriovenous fistula in the patients under hemodialysis referred​ to the clinical centers of Kerman University of Medical Sciences, in 2019</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-07-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>50</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/40632</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Crossover, Purpose: Supportive, Randomization description: samples will be randomly assigned into two blocks of 25 samples, 25 samples in acupressure/cryotherapy group and 25 samples in cryotherapy/acupressure group by Permuted Block Randomization.</study_design>
      <phase>N/A</phase>
      <hc_freetext>acute postprocedural pain of needle entry into the arteriovenous fistula.</hc_freetext>
      <i_freetext>Intervention 1: Cryotherapy/Acupressure intervention group: Session 1: routine care and no intervention will take place. Session 2: Cryotherapy will take place, as the researcher will put a cube-shaped piece of ice inside a gauze bandage, and then place it inside a plastic bag. The researcher will place the ice cube between the thumb and the index finger on the opposite hand with no fistula . After 10 minutes (2 minutes compressive massage and 15 seconds rest periodically), before the needle is inserted into the arterial-venous fistula, The researcher will rub the Hugo point (between the thumb and the index finger in the opposite hand) with average pressure. Session 3: Acupressure will take place. The researcher, using a hand thumb, will diagonally rub the Hugo point (between the thumb and the index finger in the opposite hand) with average pressure for 10 minutes for periods of 2 minutes compressive massage and 15 seconds rest before​ the needle is inserted. Intervention 2: Acupressure/Cryotherapy intervention group: Session 1: routine care and no intervention will take place. Session 2: Acupressure will take place. The researcher, using a hand thumb, will diagonally rub the Hugo point (between the thumb and the index finger in the opposite hand) with average pressure for 10 minutes for periods of 2 minutes compressive massage and 15 seconds rest before the needle is inserted. Session 3: Cryotherapy will take place, as the researcher will put a cube-shaped piece of ice inside a gauze bandage, and then place it inside a plastic bag. The researcher will place the ice cube between the thumb and the index finger on the opposite hand with no fistula. After 10 minutes (2 minutes compressive massage and 15 seconds rest periodically), before the needle is inserted into the arterial-venous fistula, The researcher will rub the Hugo point (between the thumb and the index finger in the opposite hand) with average pressure.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is I have not decided yet - its release plan is still undecided.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Seyed Javad Hosseini</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kerman University of Medical Sciences, Medical University Campus, Haft-Bagh Highway, Kerman, Iran</address>
        <city>Kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7616913555</zip>
        <telephone>+98 34 3342 7901</telephone>
        <email>hosseini4173@yahoo.com</email>
        <affiliation>Kerman University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mahlagha Dehghan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kerman University of Medical Sciences, Medical University Campus, Haft-Bagh Highway, Kerman, Iran</address>
        <city>Kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7616913555</zip>
        <telephone>+98 34 3132 5856</telephone>
        <email>m_dehghan86@yahoo.com</email>
        <affiliation>Kerman University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age over 18 years
Being conscious
Having the ability of verbal communication
3 months passed the time of fistula embedding
At least 6 months passed the time of hemodialysis Initiation
Having an active medical document (Weekly three sessions and each session for 3 to 4 hours of hemodialysis)
In case of diabetes, their diabetes has been controlled (FBS range from 70 to 150 mg/dl and BS in the range of 120 to 250 mg/dl)</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Receiving a sedative or opiate drug for 8 hours before hemodialysis
Excessive pain in other body parts
The presence of skin problem, insensibility, neuropathic disorders and peripheral vascular disease at the site of access to the vessels</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G89.18</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other acute postprocedural pain</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Cryotherapy/Acupressure intervention group: Session 1: routine care and no intervention will take place. Session 2: Cryotherapy will take place, as the researcher will put a cube-shaped piece of ice inside a gauze bandage, and then place it inside a plastic bag. The researcher will place the ice cube between the thumb and the index finger on the opposite hand with no fistula . After 10 minutes (2 minutes compressive massage and 15 seconds rest periodically), before the needle is inserted into the arterial-venous fistula, The researcher will rub the Hugo point (between the thumb and the index finger in the opposite hand) with average pressure. Session 3: Acupressure will take place. The researcher, using a hand thumb, will diagonally rub the Hugo point (between the thumb and the index finger in the opposite hand) with average pressure for 10 minutes for periods of 2 minutes compressive massage and 15 seconds rest before​ the needle is inserted.</i_keyword>
      <i_keyword>Acupressure/Cryotherapy intervention group: Session 1: routine care and no intervention will take place. Session 2: Acupressure will take place. The researcher, using a hand thumb, will diagonally rub the Hugo point (between the thumb and the index finger in the opposite hand) with average pressure for 10 minutes for periods of 2 minutes compressive massage and 15 seconds rest before the needle is inserted. Session 3: Cryotherapy will take place, as the researcher will put a cube-shaped piece of ice inside a gauze bandage, and then place it inside a plastic bag. The researcher will place the ice cube between the thumb and the index finger on the opposite hand with no fistula. After 10 minutes (2 minutes compressive massage and 15 seconds rest periodically), before the needle is inserted into the arterial-venous fistula, The researcher will rub the Hugo point (between the thumb and the index finger in the opposite hand) with average pressure.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain score in numerical visual analogue pain scale. Timepoint: Session 1: Patient's pain will be measured under normal care conditions and after entering and fixing hemodialysis arterial-venous needles. Session 2: Patient's pain will be measured after cryotherapy and entering and fixing hemodialysis arterial-venous needles. Session 3: Patient's pain will be measured after acupressure and entering and fixing hemodialysis arterial-venous needles. Method of measurement: The numerical visual analogue pain scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kerman University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-06-24</approval_date>
        <contact_name>Ethics committee of Kerman University of Medical Sciences</contact_name>
        <contact_address>Ebnesina St, Jahad Blvd, Somaye Crossroad, Kerman kerman Kerman Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
